Ariel Jasie

ARIEL JASIE, J.D., Chief Business Officer & General Counsel

Before eGenesis, Mr. Jasie most recently worked at Dermavant Sciences where he served as the chief business and strategy officer. At Dermavant, he initiated and led business development interactions for both in- and out-licensing efforts, as well as oversaw cross functional teams for both internal and external diligence. Prior, Mr. Jasie was the chief business officer at Codiak Biosciences, where he was responsible for driving all partnering efforts as well as key decision making to help the company realize the highest possible scientific and commercial value for its platform technology. Prior to Codiak, he served as the executive director for business development at Celgene Corporation, where he executed many industry leading deals. Before joining Celgene, Mr. Jasie served as in-house counsel at Reliant Pharmaceuticals through the company’s $1.6 billion acquisition to GlaxoSmithKline in 2007.

Mr. Jasie completed his J.D. at Brooklyn Law School, and his B.A. in history from the University of Maryland at College Park.